13F HOLDINGS REPORT
BROADWOOD CAPITAL INC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0000919574-24-004545
Total Value
$1.32B
Positions
7
Other Managers
1
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | STAAR SURGICAL CO | STAA | 10,768,431 | $512.7M | 38.77% |
| 2 | MONSTER BEVERAGE CORP NEW | MNST | 8,295,690 | $414.4M | 31.33% |
| 3 | AXON ENTERPRISE INC | AXON | 760,062 | $223.6M | 16.91% |
| 4 | ISHARES TR | 464287655 | 566,000 | $114.8M | 8.68% |
| 5 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 41,666,255 | $41.6M | 3.14% |
| 6 | ONCOCYTE CORP | IMDX | 4,929,066 | $14.5M | 1.10% |
| 7 | SERINA THERAPEUTICS INC | SER | 85,219 | $816,398 | 0.06% |